-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - administered by a clinician to an oral pill) or dosing regimens
(e.g., from daily dosing to once-a-month … Topic prioritization is an ongoing process; therefore, analysts meet twice
20
each month to discuss
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2
Systematic Review on Nonopioid
Pharmacologic Treatments for Chronic
Pain: Surveillance Report 2
Literature Update Period: October 2021 through December 2021
Background and Purpose
This is the second update for the 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
October 01, 2020 - Evidence Summary: Management of Colonic Diverticulitis
Comparative Effectiveness Review
Number 233
Management of Colonic Diverticulitis
Evidence Summary
Main Points
• Computed tomography (CT) diagnosis and clinical sequelae
o CT accurately diagnoses acute diverticulitis (moderate strength o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
January 01, 2005 - Layout 1
Background
Gastroesophageal reflux disease (GERD),
defined as weekly heartburn and/or acid
regurgitation, is one of the most common
health conditions affecting older
Americans. Direct costs attributable to
GERD were estimated to be $10 billion in
the United States in 2000.
Some patients have frequent, sever…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
December 01, 2017 - period was complete
(3 procedures over 6 weeks, followed by an additional 6
weeks) through the 12-month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
CER # 15:
Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Original release date
July 6, 2009
Surveillance Report (1st Assessment/cycle 1)
November, 2011
Surveillance Report (2nd Assessment/cycle 2)…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form.pdf
August 01, 2020 - Disclosure Policy and Form
EPC Key Informant and Technical Expert Agreement
The primary role of the Key Informant is to provide input on proposed review questions to help
the EPC ensure that a resulting evidence review will be useful for people making real-world
decisions.
The primary role of the Technical…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - median (IQR), 95% CI) at baseline
was 0.8(4.9), 0.4, 2.3 versus 1(3.5), 0.1, 2; p=0.98, and at 5th month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - to <6 months),
intermediate term (6 to <12 months), long term (≥1
year)
All KQs: Studies with <1-month … Chronic non-cancer pain
(HIV)
A: Daily or weekly use of
marijuana (55)
B: Monthly or 1-2 times a
month … Health
Outcomes among Adults Initiating Medical
Cannabis for Chronic Pain: A 3-month
Prospective Study
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - significantly
6
larger decreases in PTSD symptoms after 6 and 12 treatment months (mean 6-month … Posttraumatic
Diagnostic Scale score change, -5.9; mean 12-month Posttraumatic Diagnostic Scale score … change, -
4.9) compared with those in the usual care arm (mean 6-month Posttraumatic Diagnostic Scale … score change, -1.4; mean 12-month Posttraumatic Diagnostic Scale score change, -1.8) [6-month
β … = -3.81; p=0.002; 12-month β = -2.49; p=0.04].61
In 2015, investigators described an active duty soldier
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States
Evidence-based Practice Center Systematic Review Protocol
Project Title: Safety of Vaccines Used for Routine Immunization in the United States
I. Background and Objectives for the Systematic Review
Vaccines are consi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - condition, and fewer than one in five
had taken medications to prevent headaches during the
previous month … more effective than placebo for
reducing frequency and duration of migraine attacks
by 1.6 per month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: July 13, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Second
Generation Antidepressants in the Pharmacologic Treatment
of Adult Depression – An Update to a 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
May 29, 2025 - but this was analyzed by the project team and
ultimately led into an RFA that hit the street last month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population
Future Research Needs Paper
Number 10
Future Research Needs
for Hematopoietic
Stem-Cell
Transplantation
in the Pediatric
Population
Future Research Needs Paper
Number 10
Future Research Needs for Hematopoieti…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
November 01, 2012 - assistance if
the beneficiary Medicare Entitlement Buy-in indicator was between 01
and 09 in the month
-
effectivehealthcare.ahrq.gov/products/nonpharma-treatment-pain/research-2018
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - to <6 months),
intermediate term (6 to <12 months), long term (≥1
year)
All KQs: Studies with <1-month … Chronic non-cancer
pain (HIV)
A: Daily or weekly use
of marijuana (55)
B: Monthly or 1-2 times
a month … Health
Outcomes among Adults Initiating Medical
Cannabis for Chronic Pain: A 3-month
Prospective Study
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Reported costs of Bydureon from 11
U.S. pharmacies range from $354 to $469 per month or about $4,250 … The HbA1c test
measures the average amount of glucose in a patient’s blood over a 3- or 4-month period … 24, 31.4% versus 15.1% at month 30 (p=<0.001),
29% versus 17.3% at month 33 (p=0.004) and 28.7% versus … 18.9% at month 36 (p=0.018).”
34
In June 2010, the company submitted a new drug application (NDA … Reported costs of Bydureon from 11 pharmacies in the United States range
from $354 to $469 per month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
February 16, 2011 - This 3-month time frame concurs with published definitions of chronic pain,12-13
including that of the … Twice a month, the project staff will meet to discuss the results and progress to
date; review cases … This 3-month time frame concurs with published definitions of chronic pain,12-13 including
that of the